Genetic Screening Reveals Heterogeneous Clinical Phenotypes in Patients with Dilated Cardiomyopathy and Troponin T2 Variants.

Angelika WeisSvenja KrueckGregor DombrowskyAnne SchänzerChristian JuxAnselm UebingInga VogesMarc Phillip HitzStefan Rupp

Published in: Journal of personalized medicine (2023)

Family screening of patients with DCM improves risk assessment, especially for individuals who are currently asymptomatic. Screening contributes to improved treatment by enabling practitioners to set appropriate control intervals and quickly begin interventional measures, such as heart failure medication or, in selected cases, pulmonary artery banding.

Keyphrases

pulmonary artery
heart failure
risk assessment
coronary artery
pulmonary hypertension
pulmonary arterial hypertension
primary care
copy number
genome wide
emergency department
heavy metals
climate change
atrial fibrillation